Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Revolution Medicines (RVMD) EPS (Basic) (2019 - 2025)

Historic EPS (Basic) for Revolution Medicines (RVMD) over the last 7 years, with Q3 2025 value amounting to -$1.61.

  • Revolution Medicines' EPS (Basic) fell 7127.66% to -$1.61 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.18, marking a year-over-year decrease of 4153.01%. This contributed to the annual value of -$3.58 for FY2024, which is 731.69% up from last year.
  • As of Q3 2025, Revolution Medicines' EPS (Basic) stood at -$1.61, which was down 7127.66% from -$1.31 recorded in Q2 2025.
  • In the past 5 years, Revolution Medicines' EPS (Basic) registered a high of -$0.53 during Q1 2021, and its lowest value of -$1.61 during Q3 2025.
  • For the 5-year period, Revolution Medicines' EPS (Basic) averaged around -$0.9, with its median value being -$0.82 (2022).
  • Its EPS (Basic) has fluctuated over the past 5 years, first skyrocketed by 2837.84% in 2021, then crashed by 9836.07% in 2023.
  • Over the past 5 years, Revolution Medicines' EPS (Basic) (Quarter) stood at -$0.72 in 2021, then grew by 15.28% to -$0.61 in 2022, then plummeted by 98.36% to -$1.21 in 2023, then rose by 4.14% to -$1.16 in 2024, then tumbled by 38.8% to -$1.61 in 2025.
  • Its last three reported values are -$1.61 in Q3 2025, -$1.31 for Q2 2025, and -$1.13 during Q1 2025.